Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Lung Cancer

Free Subscription 23.02.2026 1 Ann Oncol 1 Ann Surg Oncol 1 Ann Thorac Surg 2 BMC Cancer 2 Cancer 2 Cancer Lett 1 Cancer Res 2 Genes Chromosomes Cancer 1 Int J Radiat Oncol Biol Phys 1 J Clin Invest 1 J Natl Cancer Inst 1 J Thorac Oncol 3 Lung Cancer 3 PLoS One 1 Proc Natl Acad Sci U S A 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Oncol

1. LI F, Zhang L
   PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).
   Ann Oncol. 2026 Feb 16:S0923-7534(26)00062-1. doi: 10.1016/j.annonc.2026.
   PubMed        
   
   

   
   Ann Surg Oncol

2. YI H, Liu M, Chen Y, Liu L, et al
   Development and Validation of a Frailty Risk Prediction Model for Preoperative Non-Small-Cell Lung Cancer Patients: A Cross-Sectional Study.
   Ann Surg Oncol. 2026 Feb 19. doi: 10.1245/s10434-026-19263.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

3. XU W, Li Z, Zheng J, Pan X, et al
   Subsegment-based versus segment-based anatomical sublobar resection for lung cancer: A propensity score-matched analysis.
   Ann Thorac Surg. 2026 Feb 17:S0003-4975(26)00140.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. LU Y, Liu P, Ma C, Liu H, et al
   Immune checkpoint inhibitor-related efficacy in non-small cell lung cancer: real-world incidence and management practices of 208 patients.
   BMC Cancer. 2026 Feb 19. doi: 10.1186/s12885-026-15738.
   PubMed        
   
   
5. LI Y, Ji Y, Wang C, Qin C, et al
   Prediction of immune checkpoint inhibitor-related pneumonitis in lung cancer: development and validation of multiple machine learning models.
   BMC Cancer. 2026 Feb 20. doi: 10.1186/s12885-026-15758.
   PubMed        
   
   

   
   Cancer

6. VENKATESWARAN S, Mantena RV, Willmann J, Zhang YH, et al
   Not all progression is equal.
   Cancer. 2026;132:e70311.
   PubMed         Abstract available
   
   
7. CITTOLIN-SANTOS GF, Rohatgi A
   Neoadjuvant therapy for patients with nonsmall cell lung cancer: Not as easy in the real world.
   Cancer. 2026;132:e70312.
   PubMed        
   
   

   
   Cancer Lett

8. HU S, Zhao Z, Zhao J, Liang Y, et al
   Protein kinase Ciota-driven macrophage infiltration mediates immunosuppression in non-small cell lung cancer.
   Cancer Lett. 2026 Feb 18:218330. doi: 10.1016/j.canlet.2026.218330.
   PubMed         Abstract available
   
   
9. YANG Y, Liu C, Yang L, Zheng S, et al
   IL-6 drives chemoimmunotherapy resistance in NSCLC by reprogramming myeloid cells and impairing cytotoxic lymphocyte function.
   Cancer Lett. 2026;641:218259.
   PubMed         Abstract available
   
   

   
   Cancer Res

10. WANG M, Song Z, Yuan H, Liu C, et al
    Protumor Macrophage Polarization Mediated by BMP2/4-ACVR1 Signaling Orchestrates an Immunosuppressive Microenvironment during Tumor Initiation.
    Cancer Res. 2026;86:954-971.
    PubMed         Abstract available
    
    

    
    Genes Chromosomes Cancer

11. GONG Q, Wei J, Xiao S
    Novel EWSR1::TEAD3 Fusion in an Adolescent With a Highly Aggressive Peritoneal Mesothelioma.
    Genes Chromosomes Cancer. 2026;65:e70113.
    PubMed         Abstract available
    
    
12. VARTY K, MacLean L, Itani D, Hossain M, et al
    Synonymous Variants of Potential Significance Identified by a 52-Gene Clinical Sequencing Panel in Non-Small Cell Lung Cancer.
    Genes Chromosomes Cancer. 2026;65:e70111.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

13. REUTER LM, Kraus KM, Fischer SM, Pletzer D, et al
    Prediction of Symptomatic Radiation Pneumonitis in Lung Cancer Patients: A Radiomics and Dosiomics Machine Learning Approach Using the Prospective Multicenter RTOG 0617 and REQUITE trials.
    Int J Radiat Oncol Biol Phys. 2026 Feb 18:S0360-3016(26)00365.
    PubMed         Abstract available
    
    

    
    J Clin Invest

14. BURNS TF, Dacic S, Chakka A, Miller E, et al
    MET alterations are enriched in lung adenocarcinoma brain metastases, defining a distinct biologic subtype.
    J Clin Invest. 2025;136:e194708.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

15. POCOBELLI G, Del Vecchio NJ, Cushing-Haugen K, Kamineni A, et al
    Up-to-date prevalence at recommended ages for discontinuing routine colorectal, cervical and lung cancer screening.
    J Natl Cancer Inst. 2026 Feb 16:djag044. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

16. ZANGHI A, Moro M, Fortunato O, Segale M, et al
    Clinical Value of Combining Molecular and Immune Blood Tests to Safely Reduce False Positives in Low-Dose CT Lung Cancer Screening.
    J Thorac Oncol. 2026 Feb 16:103614. doi: 10.1016/j.jtho.2026.103614.
    PubMed         Abstract available
    
    

    
    Lung Cancer

17. ZHONG CC, Yang Z, Chen M, Li Z, et al
    Public perceptions of lung cancer screening: a population-based assessment of acceptability and feasibility.
    Lung Cancer. 2026;214:109308.
    PubMed         Abstract available
    
    
18. MAXFIELD N, Semprini J
    Lung cancer incidence in counties at low and high risk of Radon Exposure: A Population-Based SEER analysis (1975-2022).
    Lung Cancer. 2026;214:109334.
    PubMed         Abstract available
    
    
19. BARTOLOMEO V, Jongbloed M, Huijs JWJ, Filippi AR, et al
    Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatment.
    Lung Cancer. 2026;214:109337.
    PubMed         Abstract available
    
    

    
    PLoS One

20. KOU K, Cameron J, Dasgupta P, Chen H, et al
    Generation of machine-learning derived cancer vulnerability indicator to determine the spatial burden of cancer outcomes.
    PLoS One. 2026;21:e0319539.
    PubMed         Abstract available
    
    
21. LI J, Xie Z, Chen Y, Jin G, et al
    Trends and associations of pulmonary nodule detection rates in China, 2019-2023: A multicenter cross-sectional study based on Real-World Data.
    PLoS One. 2026;21:e0343207.
    PubMed         Abstract available
    
    
22. ESHET Y, Domachevsky L, Tau N, Founshtein GP, et al
    Rapidly progressive arthropathy identified on imaging of patients treated with Crizotinib for ALK-rearranged/ROS1-positive non small cell lung cancer: A retrospective single-center study.
    PLoS One. 2026;21:e0333223.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

23. 
    Correction for Impheng et al., Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transition in lung cancer cells.
    Proc Natl Acad Sci U S A. 2026;123:e2602974123.
    PubMed        
    
    

    
    Thorax

24. HUSTA BC, Cheng GZ, Batra H, Reisenauer JS, et al
    Shape-sensing robotic-assisted bronchoscopy with integrated mobile cone-beam CT for small nodules: results from the prospective multicentre CONFIRM study.
    Thorax. 2026;81:267-275.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum